摘要
A series of α-glutamic acid scaffold based 4-(benzamido)-4-(1,3,4- oxadiazol-2-yl) butanoic acids were designed and synthesized as new ADAMTS inhibitors. The compounds dose-dependently inhibited the enzymatic activities of ADAMTS-4 and ADAMTS-5. One of the most active compound 2h potently inhibited ADAMTS-4 and ADAMTS-5 with IC 50 values of 1.2 and 0.8 μM, respectively. These inhibitors may serve as new lead compounds for further development of therapeutics to treat osteoarthritis.
| 源语言 | 英语 |
|---|---|
| 页(从-至) | 4457-4461 |
| 页数 | 5 |
| 期刊 | Bioorganic and Medicinal Chemistry Letters |
| 卷 | 21 |
| 期 | 15 |
| DOI | |
| 出版状态 | 已出版 - 1 8月 2011 |
| 已对外发布 | 是 |
指纹
探究 'Structure-activity study on a series of α-glutamic acid scaffold based compounds as new ADAMTS inhibitors' 的科研主题。它们共同构成独一无二的指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver